Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma.
Front Cell Dev Biol
; 10: 968590, 2022.
Article
in En
| MEDLINE
| ID: mdl-36467424
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Prognostic_studies
Language:
En
Journal:
Front Cell Dev Biol
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland